Table 2.
Univariate and multivariate analyses for specific hazard of relapse in patients with t(8;21) AML
| Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|
| Patients | SHR | 95% CI | P value | SHR | 95% CI | P value | |
| Age* | 106 | 1.00 | 0.97-1.03 | .938 | — | — | — |
| LogWBC* | 106 | 2.47 | 1.18-5.19 | .017† | 1.94 | 0.89-4.27 | .097 |
| TKmut and (chromatin modifiersWT and cohesinWT) | 31/106 | 3.88 | 1.20-12.54 | .023† | 3.96 | 1.22-12.91 | .022† |
| TKmut and (chromatin modifiersmut and/or cohesinmut) | 38/106 | 6.21 | 2.11-18.26 | .001† | 5.44 | 1.82-16.27 | .002† |
*
Tested as continuous variable.
†
P < .05.